TFF Pharmaceuticals (TFFP) Stock Chart & Stock Price History → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free TFFP Stock Alerts $3.01 +0.04 (+1.35%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media TFF Pharmaceuticals Stock Price Performance5 Day Performance-3.22%1 Month Performance-59.32%3 Month Performance-40.63%6 Month Performance-62.11%Year-To-Date Performance-57.12%1 Year Performance-78.11% Receive TFFP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. TFFP Stock Chart for Thursday, April, 25, 2024 TFFP Chart by TradingView TFF Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$3.03$3.01-0.50%$3.13$2.7912,712 shs$7.59 million04/23/2024$2.58$3.03+17.25%$3.14$2.5462,771 shs$7.62 million04/22/2024$3.11$2.58-17.04%$3.06$2.5147,266 shs$6.50 million04/19/2024$3.14$3.11-0.80%$3.41$3.113,671 shs$7.84 million04/18/2024$3.24$3.14-3.26%$3.47$3.0026,469 shs$7.90 million04/17/2024$3.31$3.24-2.10%$3.34$3.2021,779 shs$8.17 million Get the Latest News and Ratings for TFFP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$3.52$3.31-5.97%$3.47$3.2027,068 shs$8.34 million04/15/2024$3.85$3.52-8.57%$4.03$3.5032,246 shs$8.87 million04/12/2024$3.96$3.85-2.78%$4.26$3.8539,537 shs$9.70 million04/11/2024$4.07$3.96-2.70%$4.37$3.9212,035 shs$9.98 million04/10/2024$4.42$4.07-7.92%$4.59$3.9933,644 shs$10.26 million04/09/2024$4.26$4.42+3.76%$4.52$4.1918,775 shs$11.14 million04/08/2024$4.49$4.26-5.12%$4.61$4.2214,592 shs$10.74 million04/05/2024$4.83$4.49-7.04%$4.91$4.2543,128 shs$11.32 million04/04/2024$5.00$4.83-3.40%$5.27$4.6126,059 shs$12.17 million04/03/2024$4.93$5.00+1.42%$5.15$4.7437,802 shs$12.60 million04/02/2024$6.41$4.93-23.09%$6.34$4.84168,022 shs$11.68 million04/01/2024$6.04$6.41+6.13%$6.81$6.0542,294 shs$15.16 million03/29/2024$6.19$6.04-2.42%$7.17$5.9060,444 shs$14.32 million03/28/2024$6.59$6.19-6.07%$7.17$5.9060,427 shs$14.67 million03/27/2024$6.49$6.59+1.54%$6.85$5.9937,657 shs$15.62 million03/26/2024$7.40$6.49-12.30%$7.45$5.79115,677 shs$15.35 million03/25/2024$7.69$7.40-3.77%$7.99$7.0647,741 shs$17.54 million03/22/2024$8.21$7.69-6.33%$8.20$7.3042,539 shs$18.23 million03/21/2024$7.95$8.21+3.27%$8.25$7.3351,242 shs$19.42 million03/20/2024$8.87$7.95-10.37%$11.00$7.74273,059 shs$18.84 million03/19/2024$7.60$8.87+16.71%$9.74$7.9067,290 shs$21.02 million03/18/2024$7.37$7.60+3.12%$8.02$7.6015,813 shs$18.01 million03/15/2024$7.62$7.37-3.28%$7.90$7.3010,226 shs$17.47 million03/14/2024$7.81$7.62-2.43%$8.10$7.624,887 shs$18.06 million03/13/2024$7.81$7.81$8.91$7.812,053 shs$18.51 million03/12/2024$8.50$7.81-8.12%$9.36$7.8113,601 shs$18.47 million03/11/2024$7.89$8.50+7.73%$8.55$7.657,205 shs$20.15 million03/08/2024$8.24$7.89-4.25%$8.34$7.787,593 shs$18.70 million03/07/2024$8.03$8.24+2.62%$8.45$7.9413,057 shs$19.49 million03/06/2024$8.62$8.03-6.84%$8.52$7.2218,895 shs$19.03 million03/05/2024$8.99$8.62-4.12%$9.78$7.8017,191 shs$20.43 million03/04/2024$6.75$8.99+33.23%$9.45$6.7082,494 shs$21.31 million03/01/2024$6.13$6.75+10.08%$6.76$6.2129,114 shs$15.99 million02/29/2024$6.15$6.13-0.33%$6.40$6.0031,718 shs$14.53 millionA new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera.02/28/2024$5.26$6.15+16.92%$6.15$5.3033,830 shs$14.58 million02/27/2024$5.76$5.26-8.68%$6.12$5.2337,553 shs$12.44 million02/26/2024$5.90$5.76-2.40%$5.94$5.765,574 shs$13.65 million02/23/2024$5.90$5.90$6.00$5.7112,127 shs$13.98 million02/22/2024$6.62$5.90-10.88%$6.72$5.8212,237 shs$13.95 million02/21/2024$6.54$6.62+1.22%$6.68$6.294,476 shs$15.69 million02/20/2024$6.94$6.54-5.76%$6.90$6.2616,529 shs$15.50 million02/19/2024$6.94$6.94$7.05$6.804,300 shs$16.45 million02/16/2024$7.03$6.95-1.14%$7.04$6.804,316 shs$16.47 million02/15/2024$6.84$7.03+2.78%$7.10$6.664,343 shs$16.66 million02/14/2024$6.56$6.84+4.27%$7.03$6.518,274 shs$16.21 million02/13/2024$7.29$6.56-10.01%$7.30$6.5626,001 shs$15.55 million02/12/2024$7.10$7.29+2.68%$7.36$6.7419,661 shs$17.24 million02/09/2024$7.08$7.10+0.35%$7.20$6.846,725 shs$16.83 million02/08/2024$7.20$7.08-1.74%$7.22$6.5315,003 shs$16.77 million02/07/2024$6.40$7.20+12.50%$7.29$6.2838,963 shs$17.06 million02/06/2024$6.13$6.40+4.40%$6.49$5.3635,697 shs$15.17 million02/05/2024$5.82$6.13+5.42%$6.13$5.418,296 shs$14.53 million02/02/2024$5.23$5.82+11.28%$5.89$5.3112,279 shs$13.79 million02/01/2024$5.37$5.23-2.61%$5.47$5.225,236 shs$12.40 million01/31/2024$5.42$5.37-0.92%$5.48$5.104,702 shs$12.73 million01/30/2024$5.36$5.42+1.12%$5.42$4.7218,792 shs$12.85 million01/29/2024$5.03$5.36+6.52%$5.42$5.109,471 shs$12.68 million01/26/2024$5.07$5.03-0.79%$5.28$4.6323,232 shs$11.92 million01/25/2024$5.30$5.07-4.34%$5.29$5.056,874 shs$12.02 million01/24/2024$4.78$5.30+10.88%$5.49$5.0019,510 shs$12.56 million Related Companies: Biofrontera Stock Chart ASLAN Pharmaceuticals Stock Chart Bionomics Stock Chart Lixte Biotechnology Stock Chart Chemomab Therapeutics Stock Chart Pasithea Therapeutics Stock Chart Kineta Stock Chart Universe Pharmaceuticals Stock Chart Graybug Vision Stock Chart eFFECTOR Therapeutics Stock Chart Receive TFFP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TFFP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.